Meeting Report

Contemporary Management of Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Presented by Sandra E. Kurtin,(1) PhDc, AOCN®, ANP-C, and Ann McNeill,(2) RN, MSN, APN

1)The University of Arizona Cancer Center, Tucson, Arizona; 2)John Theurer Cancer Center, Hackensack, New Jersey

Presenters’ disclosures of conflicts of interest are found at the end of this article.


J Adv Pract Oncol 2018;9(3):351–356 | https://doi.org/10.6004/jadpro.2018.9.3.13 | © 2018 Harborside™


  

ABSTRACT

Identifying key molecular attributes can help in the risk-adapted treatment of Hodgkin lymphoma and chronic lymphocytic leukemia. At JADPRO Live, presenters reviewed best practices for managing patients with the rapidly expanding armamentarium of treatments for these patients.




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.